Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Thoracic Surgery

  Free Subscription


Articles published in Thromb Haemost

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    August 2018
  1. DUERSCHMIED D, Bode C
    Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention.
    Thromb Haemost. 2018;118:1350-1351.
    PubMed     Text format    


    June 2018
  2. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Text format     Abstract available


  3. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Text format     Abstract available


  4. WILLEMSEN L, Ten Berg J
    Platelet Inhibition and Bleeding Risks in Patients Undergoing Non-Cardiac Surgery.
    Thromb Haemost. 2018;118:953-955.
    PubMed     Text format    


    April 2018
  5. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Text format     Abstract available


  6. BOURGUIGNON T, Bernard A, Fauchier L
    Risk of Thromboembolic Events without Oral Anticoagulation at 90 Days after Surgical Aortic Valve Replacement with a Bioprosthesis.
    Thromb Haemost. 2018 Apr 4. doi: 10.1055/s-0038-1641167.
    PubMed     Text format    


    March 2018
  7. KIBLER M, Marchandot B, Messas N, Caspar T, et al
    CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement.
    Thromb Haemost. 2018 Mar 28. doi: 10.1055/s-0038-1639352.
    PubMed     Text format     Abstract available


    January 2018
  8. PAWLITSCHEK F, Keyl C, Zieger B, Budde U, et al
    Alteration of von Willebrand Factor after Transcatheter Aortic Valve Replacement in the Absence of Paravalvular Regurgitation.
    Thromb Haemost. 2018;118:103-111.
    PubMed     Text format     Abstract available


    December 2017
  9. HEWING B, Ellerbroek R, Au SC, Stangl V, et al
    Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis.
    Thromb Haemost. 2017;117:2346-2355.
    PubMed     Text format    


    August 2017
  10. ANETSBERGER A, Blobner M, Haller B, Schmid S, et al
    Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery.
    Thromb Haemost. 2017;117.
    PubMed     Text format     Abstract available


    July 2017
  11. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
    Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Thromb Haemost. 2017;117.
    PubMed     Text format     Abstract available


    June 2017
  12. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
    Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
    Thromb Haemost. 2017;117.
    PubMed     Text format     Abstract available


    February 2017

  13. Erratum to Rutten et al. "Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention" (Thromb Haemost 2016; 115: 353-360).
    Thromb Haemost. 2017;117:641.
    PubMed     Text format    


  14. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    PubMed     Text format     Abstract available


  15. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    PubMed     Text format     Abstract available


  16. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    PubMed     Text format     Abstract available


    November 2016
  17. KREUTZ RP, Schmeisser G, Maatman B, Schaffter A, et al
    Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Thromb Haemost. 2016.
    PubMed     Text format    


    October 2016
  18. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    PubMed     Text format     Abstract available


    July 2016
  19. SELLENG S, Selleng K
    Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    June 2016
  20. MEESTERS MI, Veerhoek D, de Lange F, de Vries JW, et al
    Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Thromb Haemost. 2016;116.
    PubMed     Text format     Abstract available


    January 2016
  21. FATEH-MOGHADAM S, Voesch S, Htun P, Jorbenadze R, et al
    Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
    Thromb Haemost. 2016;115:109-16.
    PubMed     Text format     Abstract available


  22. ASHER E, Fefer P, Sabbag A, Herscovici R, et al
    Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.
    Thromb Haemost. 2016;115:433-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: